Carl Phipps, MD
Otolaryngology · High Point, NCNPI 1730107020
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $625 of the $998 with a category attached, or 62.7%. Inspire Medical Systems, Inc. accounts for 64.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $712 and has fallen 84.5% since, to $110 in 2025. That places this record below the midpoint for otolaryngology clinicians in NC, where the typical reported total is $856.
Across 21 payments — averaging $47.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$642
- Optinose US, Inc.$72
- Amgen$51
- Sanofi$47
- Regeneron Healthcare Solutions, Inc.$44
- Aytu Biopharma, Inc.$34
- plus $108 from 6 others
What the payments were for
- Travel & lodging$62563%
- Food & beverage$37337%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 2 | $642 |
| Optinose US, Inc. | 4 | $72 |
| Amgen | 2 | $51 |
| Sanofi | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Aytu Biopharma, Inc. | 2 | $34 |
| KARL Storz Endoscopy-america | 1 | $28 |
| Stryker | 2 | $27 |
| GSK | 1 | $16 |
| Organogenesis Inc. | 1 | $14 |
| Aerin Medical Inc. | 1 | $12 |
| Intersect ENT, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$998 in reported general payments places this provider in the 50th percentile of 362 otolaryngology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 11 | $40,999 |
| Ipratropium Bromide | 48 | $1,459 |
| Mometasone Furoate | 16 | $926 |
| Ofloxacin | 27 | $720 |
| Fluticasone Propionate | 34 | $421 |
| Mupirocin | 26 | $314 |
| Cefdinir | 16 | $234 |
| Azelastine Hcl | 13 | $163 |
| Prednisone | 27 | $130 |
| Montelukast Sodium | 12 | $125 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $114 |
| Cephalexin | 14 | $93 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in High Point
- David JangDurham$324K
- Robert FerrisRaleigh$258K
- Adam ZanationHickory$227K
- Brent SeniorChapel Hill$91K
- Charles EbertChapel Hill$57K
- Adam CampbellWinston Salem$47K
- Harold PillsburyChapel Hill$42K
- John BuentingSylva$30K
- Brendan O ConnellCharlotte$28K
- Nicholas ThompsonChapel Hill$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.